Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative

28 Jun 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Endometrial and Cervical Cancer Treatments
Share to Genetic factors in colorectal cancer

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 29955143
DOI: 10.1038/s41379-018-0055-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiativePMID 29955143Read ↗

Expression of DNA repair proteins in endometrial cancer predicts disease outcomeSemantic proximity Read ↗

Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice.Semantic proximity Read ↗

Molecular insights into the classification of high-grade endometrial carcinomaSemantic proximity Read ↗

The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.Semantic proximity Read ↗

The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and futureSemantic proximity Read ↗

Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-DSemantic proximity Read ↗

ROLE OF cfDNA AND ctDNA TO IMPROVE THE RISK STRATIFICATION AND THE DISEASE FOLLOW-UP IN PATIENTS WITH ENDOMETRIAL CANCER: TOWARDS THE CLINICAL APPLICATIONSemantic proximity Read ↗

[Progress in molecular classification of endometrial cancer and its clinical significance].Semantic proximity Read ↗

Untitled literature recordSemantic proximity Read ↗

DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnosticsSemantic proximity Read ↗

Toward Biology-Driven Surveillance After Endometrial Cancer Treatment: A Molecular–Clinical Framework Integrating Recurrence PhenotypeSemantic proximity Read ↗

Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.